Stem Cell Directors Approve $151 Million to Commercialize Stem Cell Research
Directors of the California stem cell agency today approved $151 million in research awards aimed at commercializing stem cell research and pushing therapies into clinical treatment.
Patients and researchers cheered when the action was announced.
The awards of up to $20 million each were ratified by CIRM's governing board, which added two to the six appl…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.